Blog
RSS FeedPosted by Michael Wonder on 07 Feb 2019
Vertex fears its triplet will also face UK reimbursement battle
6 February 2019 - Vertex Pharmaceuticals' cystic fibrosis business grew more than 40% in 2018, partially because of reimbursement victories in ...
Posted by Michael Wonder on 04 Feb 2019
UK patient activist group takes aim at Orkambi patent
4 February 2019 - Calls to bypass patent adds to pressure on Vertex. ...
Posted by Michael Wonder on 04 Feb 2019
Calls for action on patients denied £100,000 cystic fibrosis drug
4 February 2019 - Ministers urged to consider revoking patent on life-extending Orkambi, which NHS cannot afford. ...
Posted by Michael Wonder on 28 Jan 2019
Cystic fibrosis patients lobby Vertex to drop drug prices
28 January 2019 - Healthcare professionals and patient groups have written to Vertex’s CEO Jeffrey Leiden in a bid to ...
Posted by Michael Wonder on 12 Nov 2018
Availability of Orkambi on the NHS
9 November 2018 - The Health and Social Care Committee has formally requested documents from Vertex Pharmaceuticals, NHS England and ...
Posted by Michael Wonder on 02 Oct 2018
Denmark funds Vertex’s cystic fibrosis drug Orkambi, UK talks deadlocked
2 October 2018 - As uncertainty hangs over the availability of Vertex’s cystic fibrosis drug in England, the company has ...
Posted by Michael Wonder on 01 Oct 2018
NHS England agrees to fund Janssen’s Symtuza
1 October 2018 - NHS England has agreed to provide funding for Janssen’s Symtuza, a once-daily darunavir-based single tablet regimen ...
Posted by Michael Wonder on 25 Sep 2018
Patients call for end to CF drug price row at key meeting
25 September 2018 - Representatives of NHS England and cystic fibrosis drug company Vertex are to meet on Thursday to ...
Posted by Michael Wonder on 19 Sep 2018
Truvada ruling could allow cheap HIV prevention in the UK
19 September 2018 - Cheap copies of Gilead’s HIV drug Truvada, which can also be used to reduce the risk ...
Posted by Michael Wonder on 23 Aug 2018
NICE publishes preliminary guidance on new combo product for AML
23 August 2018 - The Department of Health and Social Care has asked NICE to produce guidance on using liposomal cytarabine ...
Posted by Michael Wonder on 15 Aug 2018
'You have the medicine that can make me feel much better': boy, 8, pens letter asking drug company to lower prices
14 August 2018 - Watch eight-year-old Luis Walker, who has cystic fibrosis, read his letter to a pharmaceutical company urging ...
Posted by Michael Wonder on 20 Jul 2018
Orkambi: drug's maker says NHS 'undervalues' patient lives
20 July 2018 - NICE has ruled the price of the drug is too high, but the firm that makes it ...
Posted by Michael Wonder on 18 Jul 2018
Vertex mulls over NHS England’s offer for CF drugs
18 July 2018 - Vertex Pharmaceuticals is considering a final offer from NHS England on funding for its cystic fibrosis ...
Posted by Michael Wonder on 17 Jul 2018
U.K. health officials make a counteroffer to Vertex for its pricey cystic fibrosis drugs
17 July 2018 - Seeking to break a stalemate over pricey cystic fibrosis drugs, the U.K.’s National Health Service has ...
Posted by Michael Wonder on 19 Jun 2018
Patients call for end to two-year row over cystic fibrosis drug funding
19 June 2018 - UK patients are stepping up efforts to resolve the “heartbreaking” row that is denying their families ...